Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The Cambridge biotech’s treatment combats an immune and blood condition that causes severe allergic reactions to ordinary things, like a whiff of perfume or an elevated heart rate.
Blueprint Reports Positive Results from Ayvakyt Study in Non-Advanced Systemic Mastocytosis globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.